Abstract
To validate anecdotal evidence on scabies infestations, we analyzed inpatient and outpatient claims data in Germany. Scabies diagnoses increased 9-fold and treatment failure 4-fold during 2009–2018, driven mainly by persons 15–24 years of age. Prevention and control in young adults appear key because of these persons’ high mobility and social connectivity.
Highlights
Anecdotal evidence from clinicians in Germany suggests an increase in scabies; sales of scabicides by pharmacies in Germany have quadrupled during 2012–2017 [1,2]
Prevalence is highest in young children, as it was in Germany in the mid-1990s [8]
Increased incidence was reported from Croatia [10], and diagnostic data in the Netherlands since 2012 have shown an incidence increase, including outbreaks in care facilities and among students
Summary
Anecdotal evidence from clinicians in Germany suggests an increase in scabies; sales of scabicides by pharmacies in Germany have quadrupled during 2012–2017 [1,2]. The Study We analyzed claims data of outpatients insured by German statutory health insurance (SHI) funds, Author affiliations: European Centre for Disease Prevention and Control, Stockholm, Sweden Information on all ambulatory consultations and filled prescriptions of SHI-covered patients are gathered and stored up to 10 years for the SHI Physicians’ Association by the Central Research Institute of Ambulatory Health Care.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
